This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flitman-Tene, R.
Right arrow Articles by Yogev, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flitman-Tene, R.
Right arrow Articles by Yogev, D.

 Previous Article  |  Next Article 

Infection and Immunity, July 2003, p. 3821-3830, Vol. 71, No. 7
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.7.3821-3830.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Variable Lipoprotein Genes of Mycoplasma agalactiae Are Activated In Vivo by Promoter Addition via Site-Specific DNA Inversions

Ravenna Flitman-Tene,1 Sigalit Mudahi-Orenstein,1 Sharon Levisohn,2 and David Yogev1*

Department of Membrane and Ultrastructure Research, The Hebrew University-Hadassah Medical School, Jerusalem 91120,1 Mycoplasma Unit, Kimron Veterinary Institute, Beit Dagan 50250, Israel2

Received 2 December 2002/ Returned for modification 25 February 2003/ Accepted 26 March 2003


arrow
ABSTRACT
 
Mycoplasma agalactiae, the etiological agent of contagious agalactia of small ruminants, has a family of related genes (avg genes) which encode surface lipoprotein antigens that undergo phase variation. A series of 13 M. agalactiae clonal isolates, obtained from one chronically infected animal over a period of 7 months, were found to undergo major rearrangement events within the avg genomic locus. We show that these rearrangements regulate the phase-variable expression of individual avg genes. Northern blot analysis and reverse transcription-PCR showed that only one avg gene is transcribed, while the other avg genes are transcriptionally silent. Sequence analysis and primer extension experiments with two M. agalactiae clonal isolates showed that a specific 182-bp avg 5' upstream region (avg-B2) that is present as a single chromosomal copy serves as an active promoter and exhibits a high level of homology with the vsp promoter of the bovine pathogen Mycoplasma bovis. PCR analysis showed that each avg gene is associated with the avg-B2 promoter in a subpopulation of cells that is present in each subclone. Multiple sequence-specific sites for DNA recombination (vis-like), which are presumably recognized by site-specific recombinase, were identified within the conserved avg 5' upstream regions of all avg genes and were found to be identical to the recombination sites of the M. bovis vsp locus. In addition, a gene encoding a member of the integrase family of tyrosine site-specific recombinases was identified adjacent to the variable avg locus. The molecular genetic basis for avg phase-variable expression appears to be mediated by site-specific DNA inversions occurring in vivo that allow activation of a silent avg gene by promoter addition. A model for the control of avg genes is proposed.


arrow
INTRODUCTION
 
Mycoplasma agalactiae belongs to the genus Mycoplasma, which comprises more than 180 wall-less species that represent the smallest self-replicating life forms on earth and phyogenetically are related to gram-positive eubacteria (28, 29). Most mycoplasmas have been identified as infectious agents of human or other animals (29, 36). M.agalactiae, commonly known as the cause of contagious agalactia of sheep and goats, is one of the most devastating mycoplasmal pathogens of small ruminants (3). The disease is expressed clinically as mastitis, arthritis, and keratoconjunctivitis and is of a considerable economic importance worldwide, particularly in the Mediterranean basin (3). The pathogen is present in milk and other body fluids of infected animals and also in animals that do not exhibit clinical signs. These asymptomatic carrier animals play an important role in transmission of the disease (3). The successful persistence of M. agalactiae within hosts indicates that frequently the host defense mechanisms fail to eliminate the bacterial pathogen. Recent advances in the molecular biology of mycoplasmas have indicated that high-frequency variation of surface components, particularly lipoproteins, plays an important role in establishing the chronic nature of mycoplasma infections and is an important parameter in the interaction of these small wall-less bacteria with their hosts (15, 39, 40, 42). Several studies in recent years have shown that despite their limited genome capacity, the mycoplasmas are replete with mutation-based systems that provide variation in expression and structure of specific gene products as an adaptive strategy for survival (4, 12, 13, 24, 35, 41, 42).

M. agalactiae is phylogenetically closely related to Mycoplasma bovis, an important bovine pathogen that causes mastitis, arthritis, and respiratory disease and is capable of producing subacute to acute inflammations of various organs (27). The two species exhibit 99% homology in their 16S rRNA genes (26) but less than 40% homology at the genomic level (2). In previous reports it was shown that M. bovis contains an elaborate genetic system in which multiple related but divergent genes encoding variable surface lipoproteins (Vsps) undergo spontaneous on-off switching, which generates extensive surface antigenic variation (20, 25). The Vsp antigens were shown to be highly immunogenic and to contain adhesive structures in the repetitive domains of the Vsp molecules (32). Site-specific DNA inversions that occur within the vsp locus, as well intrachromosomal recombination between closely related vsp genes, dictate the degree of Vsp diversification within propagating populations by determining which vsp gene is expressed in a given cell (20, 21, 25).

Recently, a chromosomal region containing a cluster of lipoprotein-encoding genes (designated the avg genes) that undergo in vivo rearrangements in naturally infected animals was identified in M. agalactiae (9, 10). The avg genes exhibit high levels of homology in their 5' upstream regions and in their N-terminal encoding regions with the vsp genes of M. bovis, while the rest of the Avg molecule shows considerable sequence divergence. Adjacent to the vsp and avg loci there is an open reading frame that exists as a single chromosomal copy and is predicted to encode a site-specific tyrosine recombinase (31).

The present study was undertaken to investigate genomic rearrangements within the avg locus that occurred in a population during in vivo passage and the possible link between the rearrangements and phase-variable expression of the avg genes. Molecular analysis of successive M. agalactiae clonal isolates obtained from one chronically infected animal over a period of 7 months revealed that juxtaposition of a single avg promoter to silent avg genes allows transcription initiation of the recipient gene. The phase-variable expression of avg appears to be mediated by site-specific DNA inversions that occur in vivo in the natural host and closely resembles the mechanism of Vsp phase variation in M. bovis.


arrow
MATERIALS AND METHODS
 
Bacterial strains, plasmids, chemicals, and growth conditions. Type strain M. agalactiae PG2 was originally obtained from D. G. ff. Edward, Wellcome Research Laboratories, Beckenham, Kent, England. Isolation of M. agalactiae clinical isolates has been described elsewhere (10). M. agalactiae strains were grown in mycoplasma medium based on heart infusion broth (Difco) containing 0.5% yeast extract (Difco) and 20% inactivated horse serum. Escherichia coli strain DH5{alpha}MCR (Gibco BRL Life Technologies, Inc., Gaithersburg, Md.) was used as a host. Recombinant clones were constructed in the plasmid vector pKS (Stratagene, La Jolla, Calif.). E. coli cultures for plasmid isolation were grown in Luria-Bertani broth (33). Restriction enzymes, T4 ligase, and T4 polynucleotide kinase were purchased from MBI Fermentas (Amherst, N.Y.). 5-Bromo-4-chloro-3-indolyl-ß-D-galactopyranoside (X-Gal), isopropyl-ß-D-thiogalactopyranoside (IPTG), and ampicillin were purchased from Sigma Chemical Co. (St. Louis, Mo.). [{gamma}-32P]ATP, [{alpha}-32P]CTP, and {alpha}-33P-labeled deoxynucleoside triphosphates were purchased from Amersham (Little Chalfont, United Kingdom).

DNA preparation and manipulation. Genomic DNAs of M. agalactiae isolates were extracted and purified by the method of Marmur (22). Plasmid isolation, restriction endonuclease digestion, gel electrophoresis of DNA, and Southern blot hybridization were performed as previously described (19, 20).

Oligonucleotide labeling and hybridization conditions. Synthetic oligonucleotides were synthesized with a model 380B DNA synthesizer (Applied Biosystems, Inc., Foster City, Calif.). The sequences and designations of the oligonucleotides used in this study are shown in Table 1. The conditions used for oligonucleotide labeling have been described elsewhere (19, 20).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Oligonucleotides used in this study

RNA isolation and Northern blot analysis. Total cellular RNAs were extracted from mid-logarithmic-phase cultures of M. agalactiae by using an RNeasy RNA isolation kit (QIAGEN, Hilden, Germany). Total RNAs (2 µg) were denatured for 10 min at 65°C in the presence of 65% formamide and 8% formaldehyde. RNA was fractionated by electrophoresis in a 1% agarose gel containing 6% (vol/vol) formaldehyde in morpholinopropanesulfonic acid buffer (33). The High Range RNA ladder (MBI Fermentas) was included. The RNA was transferred onto nylon membranes (Schleicher & Schuell, Dassel, Germany) and prehybridized at 42°C for 2 h in a solution containing 10x Denhardt's reagent, 0.1% sodium dodecyl sulfate, 50 µg of salmon sperm DNA per ml, 6x SSPE (1x SSPE is 0.18 M NaCl plus 10 mM NaPO4 [pH 7.7]), and 1 mM EDTA (33). Hybridization was performed at 42°C. The membranes were washed twice for 10 min at room temperature and once at 42°C in 6x SSPE-0.1% sodium dodecyl sulfate. The membranes were dried and autoradiographed by using Super RX Fuji X-ray film (Fuji, Tokyo, Japan). A PCR product spanning the highly conserved signal sequence common to all avg genes was amplified by using primers pp-1 and pb-1 (Table 1.) and was used as a probe in a Northern blot analysis to monitor the presence of avg mRNA.

Primer extension. Primer pex-1 was end labeled by using T4 polynucleotide kinase and [{gamma}32P]ATP and then purified on a G-50 mini column (Boehringer Mannheim GmbH, Indianapolis, Ind.). The primer extension reaction mixture (final volume, 15 µl) contained 2 µg of total RNA, 100 ng of labeled primer, and 3.9 µl of reaction buffer (0.1 M Tris-HCl [pH 8.3], 0.14 M KCl, 10 mM MgCl2, 10 mM dithiothreitol). The reaction mixture was incubated for 10 min at 65°C, followed by 5 min at room temperature. After annealing, a deoxynucleoside triphosphate mixture (containing each deoxynucleoside triphosphate at a concentration of 2.5 mM) (Boehringer Mannheim) and 5 U of avian myeloblastosis virus reverse transcriptase (Promega) were added. The reaction mixture was incubated at 42°C for 60 min. RNase (66 µg/ml) was then added, and the reaction mixture was incubated for 30 min at 37°C; then the reaction was terminated by heat inactivation for 10 min at 70°C. Primer extension products were mixed with loading buffer and resolved on a 6% polyacrylamide sequencing gel. DNA sequence analysis was performed by the dideoxy chain termination method (34) by using a Thermo Sequenase radiolabeled terminator cycle sequencing kit (Amersham).

PCRs. PCRs were carried out in 25-µl mixtures containing 10 ng of template DNA, 1 U of ExSel DNA polymerase in 1x S-T Exsel buffer (MBI Fermentas), 2 mM MgSO4, each deoxynucleoside triphosphate at a concentration of 0.2 mM, and 125 ng of each primer. PCR amplification was performed by using a Tpersonal cycler (Biometra, Gottingen, Germany) programmed for 31 cycles as follows: one cycle of 3 min at 95°C, 45 s at 55°C, and 35 s at 72°C, followed by 30 cycles of 35 s at 95°C, 45 s at 55°C, and 30 s at 72°C. The reaction mixtures were then incubated for 10 min at 72°C and allowed to cool to 10°C. The resultant PCR products were purified by using High Pure filter columns (Boehringer Mannheim) and directly sequenced. The PCR primers used in this study are listed in Table 1.

RT-PCR. Primers rtb-1 and rtb-2 were designed from the avgB gene sequence to enable synthesis of a PCR product that was 533 bp long and spanned the avgB intergenic region. Mycoplasma RNA from isolates 627#3 and 627#4 was treated with RNase-free DNase I (MBI Fermentas) and then reverse transcribed by using the RevertAid Moloney murine leukemia virus reverse transcriptase (MBI Fermentas). The reverse transcription (RT)-PCR mixture containing 2 µg of RNA and 20 pmol of primer rtb-1 was incubated at 70°C for 5 min and then chilled on ice. Four microliters of 5x reaction buffer (MBI Fermentas), each of the four deoxynucleoside triphosphates (MBI Fermentas) at a concentration of 2.5 mM, and 20 U of RNase inhibitor (MBI Fermentas) were added, and the mixture was incubated at 37°C for 5 min. Then 200 U of RevertAid Moloney murine leukemia virus reverse transcriptase (MBI Fermentas) was added, and the reaction mixture was incubated at 42°C for 20 min. The reaction was stopped by heating the mixture at 70°C for 10 min. The resultant cDNA product was subjected to PCR by using primers rtb-1 and rtb-2 and the following program: 3 min at 95°C and then 25 cycles of 35 s at 95°C, 45 s at 56°C, and 35 s at 72°C, followed by 10 min of incubation at 72°C. PCR products were visualized after gel electrophoresis and ethidium bromide staining.

DNA sequence analysis. DNA sequence analysis of both strands was performed by the dideoxy chain termination method (34). The T7 promoter sequence and the T3 sequence located on the pKS vector, as well as avg-related sequences, were used as primers. Sequencing was done with a dye terminator cycle sequencing automatic sequencer (model ABI PRISMA 377; Perkin-Elmer, Foster City, Calif.). Sequence data were analyzed by using the AssemblyLIGN and MacVector 6.5.3 software.

Nucleotide sequence accession numbers. The nucleotide sequences of the M. agalactiae avg genomic region locus determined in this study have been deposited in the GenBank database under accession number AY195887.


arrow
RESULTS
 
Identification of an avg upstream region displaying homology to the vsp promoter of M. bovis and undergoing in vivo rearrangements. Recently, it was shown that a specific vsp upstream region (designated the A2 cassette) serves as an active promoter and that its juxtaposition to a silent vsp gene by site-specific DNA inversion allows transcription initiation of the recipient gene (20). Putative sequence-specific sites for DNA recombination (designated vis) that are presumably recognized by a site-specific recombinase were also identified (20, 31). The high level of sequence similarity of the M. agalactiae 5' avg upstream regions to the 5' upstream regions of the vsp genes (10, 19) raised the possibility that the avg locus contains an A2-related promoter that regulates the phase-variable expression of the avg genes. Comparison of the A2 nucleotide sequence (19) with all known avg genes of the M. agalactiae PG2 type strain (10) revealed that the corresponding upstream region of the avgB gene exhibits the highest level of homology to the A2 promoter of M. bovis (72%), particularly in the region encompassing the transcriptional start site and the RNA polymerase binding sites (Fig. 1). The A2-related region of the avgB gene was designated the avg-B2 cassette.



View larger version (52K):
[in this window]
[in a new window]
  		FIG. 1. Nucleotide sequence alignment of the upstream regions of the avgB gene (avg-B2) of M. agalactiae PG2 and the vspA-ON gene (vsp-A2) of M. bovis (19). Identical nucleotides are indicated by shading. The designation of each gene is indicated on the left. The numbers above the sequences indicate nucleotide positions relative to the initiation codon. The positions of the two upstream cassettes (cassette no.1 and cassette no. 2) are indicated on the right. The positions of the putative transcriptional start sites (+1) for the avg-B2 and vsp-A2 regions (20) are indicated by arrows. The positions of prokaryotic {sigma}70-dependent consensus sequences (-10) and a ribosome binding site (SD) are indicated by solid lines. The position of the 35-bp putative DNA recombination site (vis) (20, 31) is indicated by a dotted line. The binding site and its orientation for the pex-1 oligonucleotide are indicated by a solid line.

In a previous study, it was shown that in a series of clinical isolates obtained from a naturally infected ewe (designated animal #627), from which M. agalactiae was consistently isolated at each sampling time (at 2- to 4-week intervals over a period of 7 months), avg-related genomic fragments underwent in vivo rearrangements (10). We examined the possibility that the different avg genomic fingerprints observed in the M. agalactiae isolates reflected different locations of the avg-B2 cassette. To address this issue, an oligonucleotide complementary to a unique sequence of the avg-B2 region (designated pex-1) (Fig. 1) was used for Southern blot hybridization with HindIII-digested genomic DNAs of 13 M. agalactiae isolates obtained from animal #627 during the course of infection (Fig. 2, lanes 2 to 14), as well as the M. agalactiae PG2 type strain (Fig. 2, lane 1). A single HindIII genomic fragment that exhibited in vivo size variation was identified in the isolates tested (Fig. 2). When sequence analysis of the 5.3-kb HindIII fragment identified in type strain PG2 (Fig. 2, lane 1) was performed, a single copy of the avg-B2 region was identified. Collectively, these findings suggest that there is a single copy of the avg-B2 cassette in the M. agalactiae chromosome.



View larger version (48K):
[in this window]
[in a new window]
  		FIG. 2. In vivo rearrangements of M. agalactiae avg-B2-bearing genomic fragments in successive isolates from a chronically infected ewe. HindIII-digested genomic DNAs from 13 clinical isolates (lanes 2 to 14) and from the M. agalactiae PG2 type strain (lane 1) were subjected to Southern blot hybridization with an avg-B2-specific oligonucleotide probe (pex-1). The isolates were obtained from a single naturally infected animal, designated animal #627, over a period of 7 months, and M. agalactiae was consistently isolated at each sampling time (at 2- to 4-week intervals) (10). The positions of molecular size markers are indicated on the left.

M. agalactiae clonal isolates from a chronically infected animal have different avg gene configurations. Two M. agalactiae strains isolated 2 weeks apart from the same infected animal that exhibited size variation in the avg-B2-bearing genomic fragment (Fig. 2, lanes 3 and 4) (strains 627#3 and 627#4) were chosen for further study. An approximately 10-kb genomic fragment carrying the avg locus of each of the two isolates was cloned and sequenced. Within each cloned fragment, a cluster of six related avg lipoprotein genes was identified (Fig. 3). Adjacent to each locus there was a single chromosomal copy of an open reading frame, designated mar, that was predicted to encode a site-specific DNA recombinase that belongs to the {lambda} integrase family of tyrosine recombinases (31). Comparison of the nucleotide sequences of the avg loci of the two isolates revealed that major rearrangement events affecting the avg gene configuration occurred in the population during in vivo passage. For example, a 2.2-kb fragment carrying the avgA and avgE genes in isolate 627#3 (Fig. 3A) was found in isolate 627#4 in an inverted orientation (Fig. 3B). Also, the avgB gene that was located upstream of the avgC gene (Fig. 3A) was inverted and repositioned upstream of the mar gene (Fig. 3B). Moreover, a change in the organization of several upstream cassettes was observed when the two isolates were compared. Cassettes F2, D2, C2, B2, A2, and E2, which in isolate 627#3 were located upstream of the avgF, avgD, avgC, avgB, avgA, and avgE genes, respectively (Fig. 3A), in isolate 627#4 were found upstream of the avgB, avgF, avgD, avgC, avgE, and avgA genes, respectively (Fig. 3B). Notably, in addition to the variations in avg gene organization, two changes were observed in the avgB and avgC structural genes. The avgB gene in isolate 627#4 contained a stop codon at nucleotide position 496 which resulted in premature termination of translation. In addition, in isolate 627#3 there were four repeats in the avgC gene instead of the five repeats found in isolate 627#4.



View larger version (21K):
[in this window]
[in a new window]
  		FIG. 3. Schematic representation, partial restriction map, genomic organization, and comparison of the M. agalactiae avg locus for two isolates obtained 2 weeks apart from the same chronically infected ewe (animal #627). The thick solid line represents about 10 kb of the avg locus of M. agalactiae isolate 627#3 (A) or isolate 627#4 (B). The positions of HindIII (H), EcoRI (E), and XbaI (X) restriction sites are indicated. The locations and orientations of six avg genes are indicated by large shaded arrows. A solid box 5' to each avg gene represents homologous cassette no. 1. Cassette no. 2 of each avg gene is indicated. The position of the avg-B2 promoter cassette is indicated by a stippled box. The location of the putative tyrosine recombinase gene mar is indicated by a cross-hatched arrow. The open triangles indicate the location of the DNA recombination vis-like sites within conserved cassette no. 1 of each avg gene. The locations of oligonucleotide primers used in this study for PCR amplification across the junction between the avg-B2 promoter and the avg structural genes are indicated by small arrows.

The deduced proteins encoded by the six avg genes, derived from isolate 627#3, were compared, and a schematic representation of the Avg structure is shown in Fig. 4. In addition to the conserved 5' noncoding sequence, the Avg N-terminal region consisting of 25 amino acids is also a highly homologous domain; there is 93% amino acid identity in the Avg proteins and 90% homology to the corresponding region of the Vsp proteins of M. bovis (19). This peptide is a typical prokaryotic lipoprotein signal peptide, which begins with a sequence consisting of three positively charged Lys residues that is followed by a core of 20 hydrophobic amino acids and ends with the tetrapeptide Ala-Ala-Lys-Cys. The remaining portions of the mature Avg proteins show sequence divergence. Notably, unlike the abundance of repetitive domains throughout the Vsp molecules of M. bovis (19), only three Avg proteins (AvgB, AvgC, and AvgE) contained reiterated coding sequences consisting of 186, 86, and 91 amino acids (RB, RC, and RE, respectively) (Fig. 4). The RB, RC, and RE sequences were unique to the corresponding proteins and were not found in other Avg proteins.



View larger version (63K):
[in this window]
[in a new window]
  		FIG. 4. Structural features and comparison of avg genes and Avg products derived from isolate 627#3. The structures of each avg gene and predicted Avg protein are indicated schematically by aligned rectangles. A highly conserved cassette no. 1 and the cassette no. 2 upstream of each avg gene are indicated by the first two boxes. The avg-B2 promoter cassette is indicated by a gray box. The third box (solid box labeled S) represents a highly homologous 75-bp DNA sequence encoding a conserved prolipoprotein signal peptide. A 6-amino-acid sequence common to all Avgs is indicated by the fourth box (shaded box). In-frame reiterated coding sequences within the AvgB (RB1 to RB2), AvgC (RC1 to RC4), and AvgE (RE1 to RE4) proteins are represented by cross-hatched boxes. A 56-amino-acid region present once in the AvgA protein and twice in the AvgB protein or a 134-amino-acid region present in both the AvgD and AvgF proteins are cross-hatched differently. The numbers on the right indicate the length of each polypeptide chain.

avg upstream region B2 serves as an active promoter. The high level of homology of the avg-B2 cassette to the vsp-A2 promoter and the finding that in clinical isolates it was located upstream of different avg genes (avgB and avgC [Fig. 3A and B, respectively]) raised the possibility that the avg-B2 cassette is, in fact, an active promoter and that acquisition of this element by other members of the avg family activates the recipient gene. We therefore examined whether the avg-B2recipient genes, namely, the avgB gene in isolate 627#3 (Fig. 3A) and the avgC gene in isolate 627#4 (Fig. 3B), were transcribed. Total cellular RNAs of the two M. agalactiae isolates were extracted and subjected to Northern blot analysis by using two oligonucleotides complementary to a unique sequence of the avgB or avgC structural genes (pb-1 and pc-1, respectively). A single transcript was detected by the pb-1 probe only in isolate 627#3 (Fig. 5A, lane 1), while a single transcript was detected by the pc-1 probe only in isolate 627#4 (Fig. 5B, lane 2). To determine whether additional avg-related mRNA might be present in the two isolates, a Northern blot analysis was performed by using a PCR product spanning the highly conserved avg upstream region and the N-terminal region present in all known avg genes as a probe. No additional avg mRNAs were detected, suggesting that in the two clonal isolates tested the avg-B2 recipient gene is transcribed, while the other avg genes are transcriptionally silent (data not shown).



View larger version (50K):
[in this window]
[in a new window]
  		FIG. 5. Transcription analysis of M. agalactiae clonal isolates. (A and B) Northern blot analysis of isolates 627#3 (lane 1) and 627#4 (lane 2). Total cellular RNA was extracted from each isolate and probed with the pb-1-specific oligonucleotide (A) or the pc-1-specific oligonucleotide (B). The positions of transcripts corresponding to the avgB and avgC genes are indicated by arrows. (C) RT-PCR analysis of the avgB gene in isolate 627#3 (lane 1) and in isolate 627#4 (lane 2). The position of an RT-PCR product obtained with primers rtb-1 and rtb-2 designed to amplify a 533-bp fragment of the avgB structural gene identified only in isolate 627#3 is indicated (lane 1). Identical PCR products amplified from total genomic DNAs of isolates 627#3 (lane 3) and 627#4 (lane 4) by using the same primer pairs are shown. Lane M contained the molecular size marker. (D and E) Identification of the transcription start sites of the avgB and avgC genes. An autoradiogram of a 6% polyacrylamide gel used to analyze the extension products is shown. Primer extension analysis was performed by using cellular RNA extracted from isolates 627#3 (D) and 627#4 (E). The letters above the lanes indicate the dideoxynucleotides used to terminate the sequencing reactions. The positions of the resultant primer extension products of the avgB (D) and avgC (E) genes are indicated by arrows. Part of the nucleotide sequence deduced from the sequencing lanes is shown on the left in each panel. The positions of a transcriptional start site (+1) (arrow) and the sequence TATAAT, corresponding a prokaryotic {sigma}70-dependent -10 consensus sequence (brackets), are indicated.

The presence of avg mRNA corresponding to the avg-B2 recipient gene was also monitored by RT-PCR. Primers rtb-1 and rtb-2 were designed from the avgB gene sequence to enable synthesis of a 533-bp PCR product. RT-PCR amplification of the avgB gene in isolate 627#3 and in isolate 627#4 indicated that the avgB gene was transcribed only in isolate 627#3 (Fig. 5C, lane 1). No product was generated in isolate 627#4 (Fig. 5C, lane 2). Importantly, control reaction mixtures containing total cellular RNA that had been treated with DNase without reverse transcriptase yielded no PCR product (data not shown), while total genomic DNA of the both isolates yielded the expected 533-bp PCR product (Fig. 5C, lanes 3 and 4, respectively).

The role of the avg-B2 cassette as an active promoter was further examined by mapping the avg transcription start site for each of the avg-B2recipient genes (avgB and avgC) by using pex-1 as a primer with total cellular RNA obtained from isolates 627#3 and 627#4. A potential transcriptional start site was identified within the avg-B2 cassette for the avgB gene and for the avgC gene (Fig. 5D and E). This site was located 205 and 189 bp upstream of the initiation codons of the avgB and avgC genes, respectively (Fig. 1 and 5). The start site was preceded at the appropriate spacing by the sequence TATAAT, corresponding to the prokaryotic {sigma}70-dependent -10 consensus sequence. It should be noted that additional primer extension products were observed, which may be attributed to the presence of subpopulations in each isolate. Collectively, the data indicate that the avg-B2 cassette serves as an active promoter that allows transcription initiation of the recipient silent gene.

Each avg gene is associated with the avg-B2 promoter in a subpopulation of cells that is present in each clonal isolate. In a previous study, it was shown that each of the M. bovis vsp genes has in its upstream cassette no. 1 a putative DNA binding site (vis), which was identified as the recombination site for DNA inversions (20, 31). Each of the M. agalactiae avg genes that was analyzed in this study has in its upstream region an analogous vis-like site (with only one base difference compared to the vis site of M. bovis) for DNA recombination (Fig. 1). This finding, together with the finding that in each of the two isolates analyzed the avg-B2 promoter was found upstream of a distinct avg gene, suggests that a propagating population of M. agalactiae (even a propagating population of a clonal isolate) contains, in fact, an array of cells that exhibit different avg configurations in which the avg-B2 promoter can be located upstream of any avg gene. To verify this, primers were designed to PCR amplify any avg structural gene associated with the B2 active promoter. Five primers, representing unique sequences of five avg structural genes (avgA, avgB, avgC, avgD, and avgE; primers pa-2, pb-1, pc-2, pd-1, and pe-1, respectively) and a primer representing a unique sequence of the avg-B2 promoter (primer pp-1), were used. Genomic DNAs for PCRs were obtained from the M. agalactiae PG2 type strain, from M. agalactiae clonal isolates 627#3 and 627#4 (Fig. 3A and B, respectively), and from an additional isolate, isolate 627#5 isolated from animal #627 (Fig. 2, lane 5). PCR amplification of populations of DNAs from each of these strains (Fig. 6) yielded products that corresponded to amplification across the junction between the avg-B2 promoter and avgA (when primers pp-1 and pa-2 were used) (lane 1), avgB (when primers pp-1 and pb-1 were used) (lane 2), avgC (when primers pp-1 and pc-2 were used) (lane 3), avgD (when primers pp-1 and pd-1 were used) (lane 4), and avgE (when primers pp-1 and pe-1 were used) (lane 5). Sequence analysis of the resultant PCR products confirmed the presence of the avg-B2 promoter upstream of the avgA, avgB, avgC,avgD, and avgE, structural genes in the various M. agalactiae populations tested. These data demonstrate that each clonal isolate of M. agalactiae contains subpopulations of cells that have a mixture of avg configurations in which each avg gene is associated with the avg-B2 promoter.



View larger version (59K):
[in this window]
[in a new window]
  		FIG. 6. Association of the avg-B2 promoter with avg genes in a subpopulation of cells present in each subclone: PCR amplification of M. agalactiae isolates. Total genomic DNAs of the M. agalactiae PG2 type strain (A), clonal isolate 627#3 (B), clonal isolate 627#4 (C), and clonal isolate 627#5 (D) were subjected to PCR amplification across the junction between the avg-B2 promoter and five avg structural genes. The following primer pairs were used: for the avgA gene, pp-1 and pa-2 (lane 1); for the avgB gene, pp-1 and pb-1(lane 2); for the avgC gene, pp-1 and pc-2 (lane 3); for the avgD gene, pp-1 and pd-1 (lane 4); and for avgE gene, pp-1 and pe-1 (lane 5). The size of each PCR product (in base pairs) is indicated above the band.

DNA inversion model for phase-variable expression of the avg genes. Comparison of the nucleotide sequences at the 5' and 3' ends of the inverted fragments in isolates 627#3 and 627#4 (Fig. 3) revealed that the inversion events occurred within the 35-bp vis-like site present in cassette no. 1 (Fig. 1). These findings and the proximity of a gene encoding a site-specific tyrosine recombinase (Mar) to the avg locus (Fig. 3) (31) suggest that site-specific DNA inversion is a possible mechanism for control of avg genes. It should be noted that vis site-mediated DNA inversion can occur between vis copies that are in opposite orientations in the chromosome but not between copies that are oriented in the same direction. Comparison of the avg configurations of isolates 627#3 and 627#4 indicated that at least four distinct DNA inversions are required to recombine the avgC gene with the avg-B2 promoter and to generate the avg configuration identified in isolate 627#4 (Fig. 7). The sequence of the four putative inversion events is unknown. One DNA inversion could occur between the two vis sites of the avgA and avgE genes (Fig. 7A), giving rise to a 2.2-kb DNA inversion and to the configuration illustrated in Fig. 7B. A second inversion is postulated to occur between the vis sites of the avgF and avgC genes, leading to exchange of the F2 and C2 cassettes between the two genes and to orientation of the avgC gene in the chromosome in the direction opposite the direction of the avg-B2 promoter, generating the avg configuration shown in Fig. 7C. A third DNA inversion of a 5.3-kb fragment could then occur between the vis sites of avgC and avgB, generating the avg configuration shown in Fig. 7D. A fourth inversion of 2.3 kb between the vis sites of avgF and avgD could then yield the configuration identified in isolate 627#4 (Fig. 7E). The existence of the avg configuration shown in Fig. 7C was verified by PCR amplification of the region between the mar gene and the avgC gene, as well as the region between the F2 cassette and the avgC structural gene (Fig. 7F). These regions represent specific nucleotide sequences present only in that configuration. Three PCR primers spanning this region (Fig. 7C), designated pmar-1, pf-2, and pc-2, were used. A single 660-bp PCR product and a single 385-bp PCR product were obtained by using primers pmar-1 and pc-2 and primers pf-2 and pc-2, respectively (Fig. 7F). Sequence analysis of the two PCR amplicons confirmed the presence of the mar gene upstream of the avgC gene and the location of the F2 cassette upstream of the avgC gene (Fig. 7C). To verify the configuration shown in Fig. 7D, two primers (pmar-1 and pf-1) were used to amplify a region between the mar and avgF genes. Notably, the distance between the mar and avgF genes in isolate 627#3 is 0.9 kb (Fig. 7A), whereas in the intermediate configuration (Fig. 7D) the distance is 2.3 kb due to the presence of the avgB gene between the mar and avgF genes. A 2.3-kb amplicon was obtained by using these primers, and sequence analysis confirmed the existence of the specific genomic junction present only in that configuration (Fig. 7G, lane 2).



View larger version (40K):
[in this window]
[in a new window]
  		FIG. 7. Site-specific DNA inversion model for phase-variable expression of the avg genes. The genomic organizations of the avg locus of isolates 627#3 (A) and 627#4 (E) as determined by sequence analysis (see Fig. 3) are shown. The positions of HindIII (H), EcoRI (E), and XbaI (X) restriction sites are indicated. Four postulated DNA inversions yielding five distinct avg configurations (A to E) are indicated by crossed dashed lines. The open triangles indicate the locations of the putative DNA recombination sites (vis-like) within conserved cassette no. 1 upstream of all avg genes. The locations and directions of the PCR primers pc-2, pf-2, pmar-1, and pf-1 are indicated by arrows. (F) PCR amplification of M. agalactiae isolates. Primers pmar-1 and pc-2 (lanes 1 to 3) and primers pf-2 and pc-2 (lanes 4 to 6) were used to amplify 660- and 385-bp regions, respectively, shown in panel B. The M. agalactiae isolates included the PG2 type strain (lanes 1 and 4), isolate 627#3 (lanes 2 and 5), and isolate 627#4 (lane 3 and 6). (G) Primers pmar-1 and pf-1 were used to amplify a 0.9-kb product shown in panel A or a 2.3-kb product shown in panel D. The M. agalactiae isolates included isolate 627#3 (lane 1) and isolate 627#4 (lane 2). Lane M contained a molecular size marker. The sizes of the PCR products are also indicated.


arrow
DISCUSSION
 
In a previous study, it was shown that in a series of M. agalactiae clinical isolates obtained from a chronically infected animal, a chromosomal region containing a cluster of related avg genes underwent in vivo rearrangement (10). In the present study, we obtained evidence that the genomic rearrangements represent site-specific DNA inversions that occur in vivo within the avg locus and modulate avg gene expression. Phase-variable expression of the avg genes appears to involve at least three elements. The first element, a sequence-specific site (vis-like site), is necessary for site-specific DNA inversion. This site was identified in a 35-bp sequence present 37 bp upstream of each avg gene and resembles the recombination site (vis) identified upstream of each vsp gene in M. bovis (Fig. 1) (20). Since the clustered avg genes are not all oriented similarly, any two oppositely oriented vis-like copies could potentially serve as a recognition site for site-specific DNA inversions. We have shown that in the vsp inversion system of M. bovis even a short distance (550 bp) between two adjacent oppositely oriented vis sites is sufficient for a site-specific DNA inversion to occur (20). Thus, the presence of multiple vis-like sites within the M. agalactiae avg locus allows a wide spectrum of DNA inversions to occur. It should be noted that in numerous examples of bacterial site-specific DNA inversion systems that regulate phase variation of surface antigens, only two recombination sites and only one or two genes are involved (18). In contrast, the inversion systems of M. bovis and M. agalactiae are more complex and utilize multiple recombination sites to control expression of a large gene family (20, 31).

The second element is a promoter region. Only one avg upstream region (avg-B2), present as a single chromosomal copy, is recognized by RNA polymerase to initiate avg transcription. As a result, only one avg gene is transcribed, while the other avg genes are transcriptionally silent. Similarly, a single promoter was identified in the vsp system of M. bovis. However, despite the high level of nucleotide sequence similarity between the two active promoters (72%), they differ in their transcriptional start sites (Fig. 1).

The third element is a site-specific DNA recombinase. DNA site-specific recombinases are found in the chromosomes of many bacteria, where they contribute to a variety of biological processes, including the segregation of chromosomes and plasmids, the integration and excision of lysogenic bacteriophage genomes in the host, the transposition of transposable elements, and the lateral transfer of genetic material (11, 16, 18). In many bacteria, site-specific recombinases catalyze the site-specific DNA inversions that act as efficient genetic switches to allow genes encoding surface antigens to undergo high-frequency on-off switching, thereby generating antigenic variation (1, 4, 6, 7, 11, 18, 23). Two families of site-specific recombinases have been described, the resolvase invertase family and the {lambda} integrase family (8, 11, 38). Recently, Ron et al. described in three pathogenic mycoplasmas, M. agalactiae, M. bovis, and Mycoplasma pulmonis, an open reading frame predicted to encode a site-specific recombinase that belongs to the {lambda} integrase family of tyrosine recombinases (31). This gene is present as a single chromosomal copy and is adjacent to three distinct variable loci, the avg gene family in M. agalactiae, the vsp gene family in M. bovis, and the vsa gene family in M. pulmonis (31). More recently, Sitaraman et al. showed that the M. pulmonis recombinase, HvsR, alone is sufficient to catalyze site-specific DNA inversions of vrs-bearing fragments in E. coli (37). These findings appear to indicate that site-specific DNA inversions within the vsa locus occur in mycoplasmas without involvement of additional accessory proteins. It is, therefore, very likely that the recombinases Mar and Mbr, encoded by genes adjacent to the avg locus of M. agalactiae and the vsp locus of M. bovis, respectively, alone catalyze the high-frequency site-specific DNA inversions observed within these loci (20). It should be noted, however, that in several instances, site-specific DNA inversions involve auxiliary cellular factors that function as architectural components of the recombination complex to ensure proper recombination between correctly oriented sites (16, 17). The best-characterized examples of such systems are those of type 1 fimbriae from E. coli (1) and the flagellum of Salmonella enterica serovar Typhimurium (43). Global regulatory factors such H-NS (histone-like proteins), IHF (integration host factor), and Lrp (leucine response protein) play an important role in stimulating inversion events (17). For example, it has been suggested that IHF acts in concert with Lrp by bending the DNA to form two loops, thereby aligning the recombination sites so that strand exchange can occur (5, 17, 30). In avg and vsp inversion systems, site-specific DNA inversion of an approximately 5.3-kb genomic fragment (Fig. 7) and site-specific DNA inversion of an 10-kb genomic fragment (20), respectively, were identified. It seems likely that to bring the two corresponding vis sites into a position that allows strand exchange by the tyrosine recombinase to occur, an accessory factor is needed. Although such an accessory factor has not yet been identified in the mycoplasmas, this possibility cannot be excluded. The use of a member of the {lambda} integrase family of tyrosine recombinases in three Mycoplasma species to achieve high-frequency antigenic variation of surface lipoproteins by juxtaposition of a regulatory element with a silent lipoprotein gene suggests that the DNA inversion systems were acquired from a common evolutionary ancestor.

Just before submission of this paper, another group of researchers reported that site-specific DNA inversions within the vmpa locus of M. agalactiae mediate surface diversity (14). Comparison of the nucleotide sequences of the vmpa genes showed that the locus described by these workers is, in fact, the avg locus analyzed in our study. It should be noted however, that the two groups of researchers analyzed different strains. Glew et al. analyzed the vmpa locus from the PG2 type strain, while in this study we characterized the avg system from clinical isolates from an infected animal and further demonstrated that the site-specific DNA inversions occurred in vivo in the natural animal host. In addition, identification of the active promoter within the vmpa locus was based on homology with its counterpart from the vsp locus of M. bovis, implying that the transcriptional start site in the two species are identical. We mapped the transcriptional start site and showed that it differs from that in M. bovis. In the vsp promoter, it was identified 192 bp upstream of the Vsp initiation codon (20), whereas in the avg promoter (in isolate 627#3) it was mapped 205 bp upstream of the Avg initiation codon (Fig. 5).

Another important aspect that emerged from our study was the finding, obtained by PCR analysis, that each of the avg genes is sometimes associated with the B2 promoter, indicating that in propagating populations of M. agalactiae a wide spectrum of Avg phenotypes is maintained (Fig. 6). Some DNA inversions within the avg locus, such as the one that generates the configuration shown in Fig. 7B, occur between two silent genes (avgA and avgE) and do not change avg gene expression. Activation of a silent avg gene is possible when the silent avg gene is in its inverted orientation with respect to the B2 promoter. Such a configuration permits the silent gene to receive the B2 promoter via a single inversion event. Since the avg genes are located in the avg locus in different orientations, it is not possible to express each of the avg genes by a single inversion. Thus, phenotypically silent inversions within the avg locus play an important role and contribute significantly to generation of antigenic variation on the mycoplasma cell surface.

Collectively, the two studies provide compelling independent evidence demonstrating that M. agalactiae possesses a highly variable genomic locus that undergoes high-frequency site-specific DNA inversion that generates surface antigenic variation.


arrow
ACKNOWLEDGMENTS
 
This study was supported in part by research grant IS-2540-95R from BARD, The United States-Israel Binational Agricultural Research and Development Fund, and by grant 2215-1-99 from the Israel Ministry of Science to D.Y. and S.L. in collaboration with Abed Athamna, Research and Development Centre Hamesholash.

We gratefully acknowledge the collaboration of the late Eitan Rapoport and his invaluable contribution to the clinical studies on which this research is based.

R.F.-T. and S.M.-O. contributed equally to this work.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Membrane and Ultrastructure Research, The Hebrew University-Hadassah Medical School, Jerusalem, 91120, Israel. Phone: 972-2-6758176. Fax: 972-2-6784010. E-mail: yogev{at}cc.huji.ac.il. Back

Editor: V. J. DiRita


arrow
REFERENCES
 
    1
  1. Abraham, J. M., C. S. Freitag, J. R. Clements, and B. I. Eisenstein. 1985. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc. Natl. Acad. Sci. USA 82:5724-5727.[Abstract/Free Full Text]
    2. 2
  2. Askaa, G., and H. Erno. 1976. Elevation of Mycoplasma agalactiae subsp. bovis to species rank: Mycoplasma bovis (Hale et. al.) comb. nov. Int. J. Syst. Bacteriol. 26:323-325.[Abstract/Free Full Text]
    3. 3
  3. Bergonier, D., X. Berthelot, and F. Poumarat. 1997. Contagious Agalactia of small ruminants: current knowledge concerning epidemiology, diagnosis and control. Rev. Sci. Tech. Off. Int. Epizoot. 16:848-873.
    4. 4
  4. Bhugra, B., L. L. Voelker, N. Zou, H. Yu, and K. Dybvig. 1995. Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions. Mol. Microbiol. 18:703-714.[CrossRef][Medline]
    5. 5
  5. Blomfield, I. C., D. H. Kulasekara, and B. I. Eisenstein. 1997. Integration host factor stimulates both FimB- and FimE-mediated site-specific DNA inversion that controls phase variation of type 1 fimbriae expression in Escherichia coli. Mol. Microbiol. 23:705-717.[CrossRef][Medline]
    6. 6
  6. Boot, H. J., C. P. A. M. Kolen, and P. H. Pouwels. 1996. Interchange of the active and silent S-layer protein genes of Lactobacillus acidophilus by inversion of the chromosomal slp segment. Mol. Microbiol. 21:799-809.[CrossRef][Medline]
    7. 7
  7. Dybvig, K. 1993. DNA rearrangements and phenotypic switching in prokaryotes. Mol. Microbiol. 10:465-471.[CrossRef][Medline]
    8. 8
  8. Esposito, D., and J. J. Scocca. 1997. The integrase family of tyrosine recombinases: evolution of a conserved active site domain. Nucleic Acids Res. 25:605-3614.
    9. 9
  9. Flitman-Tene, R., S. Levisohn, R. F. Rosenbusch, E. Rapoport, and D. Yogev. 1997. Genetic variation among Mycoplasma agalactiae isolates detected by the variant surface lipoprotein gene (vspA) of Mycoplasma bovis. FEMS Microbiol. Lett. 156:123-128.[Medline]
    10. 10
  10. Flitman-Tene, R., S. Levisohn, R. F. Rosenbusch, E. Rapoport, and D. Yogev. 2000. A chromosomal region of Mycoplasma agalactiae containing vsp-related genes undergoes in vivo rearrangement in naturally infected animals. FEMS Microbiol. Lett. 191:205-212.[CrossRef][Medline]
    11. 11
  11. Glasgow, A. C., K. T. Hughes, and M. I. Simon. 1989. Bacterial DNA inversion systems, p. 637-659. In E. Berg and M. M. Howe (ed.), Mobile DNA. American Society for Microbiology, Washington, D.C.
    12. 12
  12. Glew, M. D., N. Baseggio, P. F. Markham, G. F. Browning, and I. D. Walker. 1998. Expression of the pMGA genes of Mycoplasma gallisepticum is controlled by variation in the GAA trinucleotide repeat lengths within the 5' noncoding regions. Infect. Immun. 66:5833-5841.[Abstract/Free Full Text]
    13. 13
  13. Glew, M. D., L. Papazisi, F. Poumarat, D. Bergonier, R. Rosengarten, and C. Citti. 2000. Characterization of a multigene family undergoing high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae. Infect. Immun. 68:4539-4548.[Abstract/Free Full Text]
    14. 14
  14. Glew, M. D., M. Marenda, R. Rosengarten, and C. Citti. 2002. Surface diversity in Mycoplasma agalactiae is driven by site-specific DNA inversions within the vpma multigene locus. J. Bacteriol. 184:5987-5998.[Abstract/Free Full Text]
    15. 15
  15. Gumulka-Smith, J., A. Teachman, A-H. T. Tu, J. W. Simecka, J. R. Lindsey, and K. Dybvig. 2001. Variations in the surface proteins and restriction enzymes of Mycoplasma pulmonis in the respiratory tract of infected rats. Mol. Microbiol. 40:1037-1044.[CrossRef][Medline]
    16. 16
  16. Hallet, B., and D. J. Sherrat. 1997. Transposition and site-specific recombination: adapting DNA cut-and-paste mechanisms to a variety of genetic rearrangements. FEMS Microbiol. Rev. 21:157-178.[CrossRef][Medline]
    17. 17
  17. Henderson, I. R., P. Owen, and J. P. Ntaro. 1999. Molecular switches—the ON and OFF of bacterial phase variation. Mol. Microbiol. 33:919-932.[CrossRef][Medline]
    18. 18
  18. Komano, T. 1999. Shufflons: mutiple inversion systems and integrons. Annu. Rev. Genet. 33:171-191.[CrossRef][Medline]
    19. 19
  19. Lysnyansky, I., K. Sachse, R. Rosenbusch, S. Levisohn, and D. Yogev. 1999. The vsp locus of Mycoplasma bovis: gene organization and structural features. J. Bacteriol. 181:5734-5741.[Abstract/Free Full Text]
    20. 20
  20. Lysnyansky, I., Y. Ron, and D. Yogev. 2001. Juxtaposition of an active promoter to vsp genes via site-specific DNA inversions generates antigenic variation in Mycoplasma bovis. J. Bacteriol. 183:5698-5708.[Abstract/Free Full Text]
    21. 21
  21. Lysnyansky, I., Y. Ron, K. Sachse, and D. Yogev. 2001. Intrachromosomal recombination within the vsp locus of Mycoplasma bovis generates a chimeric variable surface lipoprotein antigen. Infect. Immun. 69:3703-3712.[Abstract/Free Full Text]
    22. 22
  22. Marmur, J. 1961. A procedure for the isolation of deoxyribonucleic acid from microorganisms. J. Mol. Biol. 3:208-218.
    23. 23
  23. Moses, E. K., R. T. Good, M. Sinistaj, S. J. Billington, C. J. Langford, and J. I. Rood. 1995. A multiple site-specific DNA-inversion model for the control of Omp1 phase and antigenic variation in Dichelobacter nodosus. Mol. Microbiol. 17:183-196.[CrossRef][Medline]
    24. 24
  24. Noormohammadi, A. H., P. F. Markham, A. Kanci, K. G. Whithear, and G. F. Browning. 2000. A novel mechanism for control of antigenic variation in the haemagglutinin gene family of Mycoplasma synoviae. Mol. Microbiol. 35:911-923.[CrossRef][Medline]
    25. 25
  25. Nussbaum, S., I. Lysnyansky, K. Sachse, S. Levisohn, S., and D. Yogev. 2002. Extended repertoire of genes encoding variable surface lipoproteins in Mycoplasma bovis strains. Infect. Immun. 70:2220-2225.[Abstract/Free Full Text]
    26. 26
  26. Pettersson, B., M. Uhlem, and K. E. Johansson. 1996. Phylogeny of some mycoplasmas from ruminants based on 16S rRNA sequences and definition of a new cluster within the Hominis group. Int. J. Syst. Bacteriol. 46:1093-1098.[Abstract/Free Full Text]
    27. 27
  27. Pfützner, H., and K. Sachse. 1996. Mycoplasma bovis as an agent of mastitis pneumonia, arthritis and genital disorders in cattle. Rev. Sci. Tech. Off. Int. Epizoot. 15:1477-1494.
    28. 28
  28. Razin, S. 1992. Peculiar properties of mycoplasmas: the smallest self-replicating prokaryotes. FEMS Microbiol. Lett. 100:423-432.
    29. 29
  29. Razin, S., D. Yogev, and Y. Naot. 1998. Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev. 62:1094-1156.[Abstract/Free Full Text]
    30. 30
  30. Roesch, P. L., and I. C. Blomfield. 1988. Leucine alters the interaction of the leucine-responsive regulatory protein (Lrp) with the fim switch to stimulate site-specific recombination in Escherichia coli. Mol. Microbiol. 27:751-761.
    31. 31
  31. Ron, Y., R. Flitman-Tene, K. Dybvig, and D. Yogev. 2002. Identification and characterization of a site-specific tyrosine recombinase within the variable loci of Mycoplasma bovis, Mycoplasma pulmonis and Mycoplasma agalactiae. Gene 292:205-211.[CrossRef][Medline]
    32. 32
  32. Sachse, K., J. H. Helbig, I. Lysnaynsky, C. Grajetzki, W. Muller, E. Jacobs, and D. Yogev. 2000. Epitope mapping of immunogenic and adhesive structures in repetitive domains of Mycoplasma bovis variable surface lipoproteins. Infect. Immun. 68:680-687.[Abstract/Free Full Text]
    33. 33
  33. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
    34. 34
  34. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.[Abstract/Free Full Text]
    35. 35
  35. Shen, X., J. Gumulak, H. Yu., C. T. French, N. Zou, and K. Dybvig. 2000. Gene rearrangements in the vsa locus of Mycoplasma pulmonis. J. Bacteriol. 182:2900-2908.[Abstract/Free Full Text]
    36. 36
  36. Simecka, J. W., J. K. Davis, M. K. Davidson, S. E. Ross, C. T. K.-H. Stadtländer, and G. H. Cassell. 1992. Mycoplasma diseases of animals, p. 391-416. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C.
    37. 37
  37. Sitaraman, R., A. M. Denison, and K. Dybvig. 2002. A unique bifunctional site-specific DNA recombinase from Mycoplasma pulmonis. Mol. Microbiol. 46:1033-1040.[CrossRef][Medline]
    38. 38
  38. Stark, W. M., M. R. Boocock, and D. J. Sherratt. 1992. Catalysis by site-specific recombinases. Trends Genet. 8:432-439.[Medline]
    39. 39
  39. Wise, K. S., D. Yogev, and R. Rosengarten. 1992. Antigenic variation, p. 473-489. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C.
    40. 40
  40. Wise, K. S. 1993. Adaptive surface variation in mycoplasmas. Trends Microbiol. 1:59-63.[CrossRef][Medline]
    41. 41
  41. Yogev, D., R. Rosengarten, R. Watson-McKown, and K. S. Wise. 1991. Molecular basis of Mycoplasma surface antigenic variation: a novel set of divergent genes undergo spontaneous mutation of periodic coding regions and 5' regulatory sequences. EMBO J. 10:4069-4079.[Medline]
    42. 42
  42. Yogev, D., G. F. Browning, and K. S. Wise. 2002. Genetic mechanisms of surface variation, p. 417-443. In S. Razin and R. Hermann (ed.), Molecular biology and pathogenicity of mycoplasmas. Kluver Academic/Plenum Publishers, New York, N.Y.
    43. 43
  43. Zieg, J., M. Silverman, M. Hilmen, and M. Simon. 1977. Recombinational switch for gene expression. Science 196:170-171.[Abstract/Free Full Text]

Infection and Immunity, July 2003, p. 3821-3830, Vol. 71, No. 7
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.7.3821-3830.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Nouvel, L.-X., Marenda, M., Sirand-Pugnet, P., Sagne, E., Glew, M., Mangenot, S., Barbe, V., Barre, A., Claverol, S., Citti, C. (2009). Occurrence, Plasticity, and Evolution of the vpma Gene Family, a Genetic System Devoted to High-Frequency Surface Variation in Mycoplasma agalactiae. J. Bacteriol. 191: 4111-4121 [Abstract] [Full Text]  
  • Cimerman, A., Pacifico, D., Salar, P., Marzachi, C., Foissac, X. (2009). Striking Diversity of vmp1, a Variable Gene Encoding a Putative Membrane Protein of the Stolbur Phytoplasma. Appl. Environ. Microbiol. 75: 2951-2957 [Abstract] [Full Text]  
  • Denison, A. M., Clapper, B., Dybvig, K. (2005). Avoidance of the Host Immune System through Phase Variation in Mycoplasma pulmonis. Infect. Immun. 73: 2033-2039 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flitman-Tene, R.
Right arrow Articles by Yogev, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flitman-Tene, R.
Right arrow Articles by Yogev, D.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»